Radhika Bansal

1.8k citations
60 papers · 668 indexed · h-index 14
Topics
CAR-T cell therapy research (33 papers)Multiple Myeloma Research and Treatments (9 papers)Biosimilars and Bioanalytical Methods (9 papers)
Journals
Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Radhika Bansal

54 papers receiving 655 citations

Peers

Radhika Bansal
Comparison fields: 5 of 111
  • Oncology 282
  • Molecular Biology 146
  • Hematology 136
  • Pharmaceutical Science 72
  • Surgery 69
Replace Alessia Villani with:
Alessia Villani Italy
Shaobing Wang China
Demetrios Ioannides Greece
Carmen Cantisani Italy
Dan Liu China
Yicheng Zhang China
Kun He China
Safa Tahmasebi Iran
Hsiung‐Fei Chien Taiwan
Radhika Bansal relative to Alessia Villani Italy Alessia Villani's profile →
Citations per field
00.5×
Alessia Villani · 1×
Citations per year

Countries citing papers authored by Radhika Bansal

Since Specialization
Citations

This map shows the geographic impact of Radhika Bansal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radhika Bansal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radhika Bansal more than expected).

Fields of papers citing papers by Radhika Bansal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radhika Bansal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radhika Bansal. The network helps show where Radhika Bansal may publish in the future.

Co-authorship network of co-authors of Radhika Bansal

This figure shows the co-authorship network connecting the top 25 collaborators of Radhika Bansal. A scholar is included among the top collaborators of Radhika Bansal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radhika Bansal. Radhika Bansal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 29
3 1
4 0
5 0
6 1
7 1
8 1
9 13
10 12
11 2
12 15
13 2
14 5
15 75
16 57
17 1
18 1
19 0
20 5

About Radhika Bansal

Radhika Bansal is a scholar working on Oncology, Hematology and Immunology, having authored 60 papers that have together received 668 indexed citations. Recurring topics across this work include CAR-T cell therapy research (33 papers), Multiple Myeloma Research and Treatments (9 papers) and Biosimilars and Bioanalytical Methods (9 papers). The work is most often cited by research in Hematology (136 citations), Pharmaceutical Science (72 citations) and Oncology (282 citations). Radhika Bansal has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Sunita Gupta, Michael Craigen, Sanjeev Gupta, Nidhi Jindal, Sagar Rakshit, Shaji Kumar, Yi Lin, Yucai Wang, Sikander Ailawadhi and Melissa Alsina. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026